TRANSGENIC ANIMALS HAVING MAIN ALZHEIMER'S DISEASE-RELATED DISORDERS Russian patent published in 2009 - IPC A01K67/27 C12N5/10 C12N15/12 C12N15/63 C12Q1/02 C07K14/47 

Abstract RU 2373707 C2

FIELD: medicine.

SUBSTANCE: invention relates to field of genetic engineering and medicine. Described is animal, non-human, having sequence of nucleic acid encoding presenilin 1, carrying mutations, corresponding to M233T and L235P mutations in PS1 protein of mouse. Animal also contains sequence of nucleic acid, encoding whole gene or part of gene, encoding APP. APP protein represents APP751, originates from human and carries mutations Swedish and London. Animal is intended for application in fight against Alzheimer's disease. Also described are PS1 protein and encoding it nucleic acid.

EFFECT: invention can be used in medicine for discovering compounds intended for Alzheimer's disease treatment.

20 cl, 50 dwg, 1 tbl, 8 ex

Similar patents RU2373707C2

Title Year Author Number
INVENTION OF PROTEIN PI4KIIIA AND RELATED MEMBRANE PROTEIN COMPLEX IN TREATMENT OF ALZHEIMER'S DISEASE 2016
  • Huang Fude
  • Zhang Xiao
  • Wang Wenan
  • Zhang Le
  • Jiang Lixiang
  • Zhu Tong
  • Liu Haiyan
  • Zhou Yudong
  • He Yang
  • Wei Wanguo
RU2724493C2
METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS 2013
  • Devidson, Beverli, L.
  • Khajmen, Bredli, T.
RU2673484C2
METHOD FOR OBTAINING ANIMAL BEING DISTINCT AGAINST A MAN WITH A CERTAIN MUTATED GENE, METHOD FOR TESTING SUBSTANCE TO BE APPLIED FOR TREATING ALZHEIMER'S DISEASE (VARIANTS), PLASMID (VARIANTS), METHOD FOR OBTAINING PRIMARY CELL CULTURE OR SUBCULTIVATED CELL 1999
  • Takeda Masatosi
  • Takeda Dzundzi
RU2266002C2
COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL DISTURBANCES 2005
  • Frenkel' Dehn
  • Maron Rut
  • Bert Dehvid
  • Uehjner Khovard L.
RU2387453C2
MONOCLONAL ANTIBODIES AND APPLICATIONS THEREOF 2006
  • Labkovski Boris
  • Bargkhorn Shtefan
  • Khillen Khajnts
  • Ehbert Ul'Rikh
  • Shtribinger Andreas R.
  • Keller Patrik
RU2432362C2
HYDROCORTISONE DERIVATIVE FOR ALZHEIMER'S DISEASE TREATMENT 2019
  • Guzhova Irina Vladimirovna
  • Kozin Sergej Aleksandrovich
  • Lazarev Vladimir Fedorovich
  • Makarov Aleksandr Aleksandrovich
  • Margulis Boris Aleksandrovich
  • Mitkevich Vladimir Aleksandrovich
  • Mikhajlova Elena Radislavovna
  • Suezov Roman Vladimirovich
RU2748437C2
ANTISUBSTANCES AGAINST GLOBULOMER Aβ, THEIR ANTIGEN-BINDING PARTS, CORRESPONDING HYBRIDOMAS, NUCLEIC ACIDS, VECTORS, HOST CELLS, WAYS OF PRODUCTION OF MENTIONED ANTISUBSTANCES, COMPOSITIONS CONTAINING MENTIONED ANTISUBSTANCES, APPLICATION OF MENTIONED ANTISUBSTANCES AND WAYS OF APPLICATION OF MENTIONED ANTISUBSTANCES 2006
  • Bargkhorn Shtefan
  • Ehbert Ul'Rikh
  • Khillen Khajnts
  • Keller Patrik
  • Shtribinger Andreas
  • Labkovskij Boris
RU2442793C2
IMPROVED PROTOFIBRIL-SELECTIVE ANTIBODIES AND USE THEREOF 2007
  • Ellerfors Per
  • Lannfel'T Lars
  • Selin Dag
  • Ehkkhol'M Pettersson Frida
  • Ehnglund Khillevi
RU2429244C2
METHOD OF PREVENTING AND TREATING NEURODEGENERATIVE DISEASES 2009
  • Pazinetti Dzhulio Maria
  • Kho Lap
  • Van Tszjun'
RU2496502C2
PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF ALZHEIMER-TYPE DEMENTIA 2013
  • Wang, Chang Yi
RU2811687C2

RU 2 373 707 C2

Authors

Kasas Lousao Kati

Benua Patrik

Prad'E Loran

Tremp Gjunter

It'E Zhan-Mishel'

Blanshar-Brezhon Veronik

Dates

2009-11-27Published

2004-09-27Filed